Announcements
盛德助力英诺赛科完成新股配售
July 29, 2025
盛德代表配售代理助力英诺赛科(苏州)科技股份有限公司(HKEX: 2577)(英诺赛科)成功完成根据一般授权配售新H股项目。本次配售共发行1358万股新H股,配售事项所得款项净额约5.45亿港元(约6968万美元)。联席配售代理为中信里昂证券有限公司和海通国际证券有限公司。
本次配售所得款项将支持英诺赛科的产品升级迭代,拓展新产品应用的技术研发以增强产品竞争力,提高氮化镓产品在终端市场的渗透率。
盛德团队由合伙人律师丁锰及余嘉慧牵头,其他成员包括资深顾问律师许黎明及资深主办律师王清珑。
盛德的股权资本市场业务连续十载荣获《钱伯斯大中华区/亚太法律指南》的排名,更荣获备受瞩目的Law.com International亚洲法律大奖(Asia Legal Awards)2024“年度最佳证券律所”(Securities Firm of the Year)大奖,及获评《商法》2025年度 “境外资本市场”卓越律所大奖。
Contacts
Capabilities
Suggested News & Insights
Sidley Represents HealthCare Royalty in Monetization Agreement for Modeyso Commercial RoyaltiesApril 24, 2026Sidley Represents Underwriters in Connection With National Healthcare Properties’ US$462 Million Public OfferingApril 23, 2026Sidley Represents Liberty Mutual in US$750 Million Senior Notes OfferingApril 23, 2026Sidley Represents Cboe Global Markets in Its US$300 Million Sale of Cboe Australia and Cboe Canada to TMX GroupApril 22, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026Sidley Represents Opus Genetics in US$155 Million Financing With Oberland CapitalApril 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

